Non-small cell lung cancer with brain metastasis and ALK targeted therapy

Non-small cell lung cancer and brain metastasis Previously, non-small cell lung cancer (NSCLC) brain metastases had a poor prognosis, with a median survival time of 7 months. But tumor-specific mutations have triggered a wave of ..

Iressa Trocaine in the treatment of EGFR-mutated non-small cell lung cancer

Cancer genetic testing Cancer gene testing guides targeted therapy as the core technology for precise cancer treatment. Every cancer patient should perform cancer gene testing for himself, looking for effective targeted drugs and ..

Genetic testing guides the treatment of ALK positive lung cancer

Cancer genetic testingCancer gene testing guides targeted therapy as the core technology for precise cancer treatment. Every cancer patient should perform cancer gene testing for himself, looking for effective targeted drugs and c..

EDGE non-invasive tumor radiosurgery for lung cancer

Cancer related deaths in United StatesThe American Cancer Society published its 2015 annual cancer statistics report online on January 5, 2015. The cancer death rate in the United States has fallen by 22% from its peak in 1991 to ..

Multiple genetic testing of lung cancer tumors

A study published online in the Journal of the American Medical Association on May 21st showed that multiple genetic tests of lung cancer tumors can help select genetic abnormalities for targeted therapy. Compared with patients w..

Stereotactic radiotherapy for lung cancer that cannot be surgically removed

Stereotactic body radiation therapyStereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy (SABR). Since its application in the mid-1990s, SBRT has distinguished itself in the radical treatmen..

Instructions for using Opdivo -nivolumab for patients with non-small cell lung cancer

Opdivo has been listed in the United States for the treatment of lung cancer. Many cancer patients cannot go abroad for treatment for various reasons. Consult Opdivo on how to use it and hope to be able to buy medicine from abroad..

Anti-cancer drug Opdivo becomes the first PD-1 drug to cure lung cancer

On January 13, 2015, Huanyu Dakang Medical News pharmaceutical giant Squibb Company ushered in a good start in 2015. The anti-cancer immunotherapy drug nivolumab developed by the company was approved last month under the trade na..

Lung cancer case study and clinical trial

1. Diagnosis and first treatment of lung cancerPatient Lu was diagnosed with lung adenocarcinoma and lymph node metastasis on August 26, 2005. A left lower lobectomy was performed on September 22, 2005. Carboplatin combined with ..

Classification

Classification of lung adenocarcinoma and surgical perspective of lung cancer

1. Individualized scope of lung parenchymal resection Since the 1960s, regardless of tumor size, anatomical lobectomy has become the standard for surgical treatment of non-small cell lung cancer . However, the lung function o..